SEC Company Response from Charming Medical Ltd (MCTA) (CIK 0002035992) (MCTA) — Sep 29, 2025
Charming Medical Ltd (MCTA) (CIK 0002035992)
Date: Sept. 29, 2025 · CIK: 0002035992 · Accession: 0001213900-25-092640
AI Filing Summary & Sentiment
File numbers found in text: 333-287258
Letter
Re: Charming Medical Limited (CIK: 0002035992)
September 29, 2025
VIA EDGAR
Division of Corporation Finance
U.S. Securities & Exchange Commission
100 F Street, NE
Washington, D.C. 20549
Registration Statement on Form F-1 (File No. 333-287258) (the “Registration Statement”)
Ladies and Gentlemen:
Pursuant to Rule 461 of the General Rules and Regulations under the Securities Act of 1933, as amended (the “Act”), the undersigned, for itself and the other underwriters, hereby joins in the request of Charming Medical Limited that the effective date of the above-referenced registration statement be accelerated so as to permit it to become effective at 5:15 p.m., Eastern time, on Tuesday, September 30, 2025, or as soon thereafter as practicable.
Pursuant to 460 under the Act, we wish to advise you that the underwriters have distributed as many electronic copies of the proposed form of preliminary prospectus to underwriters, dealers, institutions and others as appears to be reasonable to secure adequate distribution of such preliminary prospectus.
The undersigned advises that it has complied and will continue to comply with the requirements of Rule 15c2-8 under the Securities Exchange Act of 1934, as amended.
Very truly yours,
Cathay Securities, Inc.
Show Raw Text
CORRESP
1
filename1.htm
September 29, 2025
VIA EDGAR
Division of Corporation Finance
U.S. Securities & Exchange Commission
100 F Street, NE
Washington, D.C. 20549
Re:
Charming Medical Limited (CIK: 0002035992)
Registration Statement on Form F-1 (File No. 333-287258) (the “Registration Statement”)
Ladies and Gentlemen:
Pursuant to Rule 461 of the
General Rules and Regulations under the Securities Act of 1933, as amended (the “Act”), the undersigned, for
itself and the other underwriters, hereby joins in the request of Charming Medical Limited that the effective date of the above-referenced
registration statement be accelerated so as to permit it to become effective at 5:15 p.m., Eastern time, on Tuesday, September 30, 2025,
or as soon thereafter as practicable.
Pursuant to 460 under the
Act, we wish to advise you that the underwriters have distributed as many electronic copies of the proposed form of preliminary prospectus
to underwriters, dealers, institutions and others as appears to be reasonable to secure adequate distribution of such preliminary prospectus.
The undersigned advises that
it has complied and will continue to comply with the requirements of Rule 15c2-8 under the Securities Exchange Act of 1934, as amended.
Very truly yours,
Cathay Securities, Inc.
As representative of the underwriters
By:
/s/ Shell Li
Name:
Xiaoyu (Shell) Li
Title:
Chief Executive Officer